GlassScriptPhysician profile
Muhammad I Choudhry
NPI 1710197363
$10,903.76
in general payments reported to CMS, 2019-2025
61 companies · $2,081 in 2025
The $2,081 reported for 2025 was more than what 77% of Endocrinology, Diabetes & Metabolism providers received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $870 · 2020: $1,232 · 2021: $1,180 · 2022: $1,585 · 2023: $2,163 · 2024: $1,794 · 2025: $2,081.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,985 · Education: $52.71.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,984.76 |
| Education | $52.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $1,231.41 | 2019-2025 | Mounjaro, Zepbound, Lyumjev |
| Astrazeneca Pharmaceuticals LP | $1,176.36 | 2019-2023 | Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $878.48 | 2019-2025 | Jardiance |
| Novo Nordisk INC | $715.60 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Corcept Therapeutics | $649.57 | 2019-2025 | Korlym |
| Mannkind Corporation | $605.90 | 2020-2025 | Afrezza |
| Abbott Laboratories | $572.45 | 2019-2025 | Freestyle Libre 3, Proclaim |
| Xeris Pharmaceuticals, INC. | $461.69 | 2020-2025 | Recorlev, Gvoke Hypopen |
| Sanofi-Aventis U.S. LLC | $431.91 | 2019-2025 | |
| Medtronic, INC. | $357.26 | 2021-2024 | Minimed 780g, Minimed 770g, Intellis Adaptivestim |
| Amgen INC. | $350.68 | 2021-2025 | Tepezza, Repatha, Evenity |
| Tandem Diabetes Care, INC. | $233.19 | 2022-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Recordati_rare_diseases_inc. | $225.62 | 2022-2025 | Isturisa, Signifor Lar |
| Insulet Corporation | $198.00 | 2019-2025 | Omnipod |
| Abbvie INC. | $171.54 | 2021-2025 | Synthroid |
Show all 61 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cequr Corporation | $171.32 | 2022-2025 | Cequr Simplicity |
| Dexcom, INC. | $148.42 | 2021-2025 | Dexcom G6 Transmitter |
| Endo USA, INC. | $146.63 | 2024-2025 | Aveed |
| Beta Bionics, INC. | $141.95 | 2023-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Merck Sharp & Dohme LLC | $113.79 | 2019-2021 | |
| Nevro Corp. | $105.52 | 2023-2024 | Senza |
| Vivus LLC | $101.46 | 2023-2025 | Qsymia |
| Radius Health, INC. | $101.45 | 2023-2025 | Tymlos |
| Kyowa Kirin, INC. | $100.87 | 2023-2025 | Crysvita |
| Bayer Healthcare Pharmaceuticals INC. | $96.36 | 2021-2024 | |
| Zealand Pharma US, INC. | $92.39 | 2020-2022 | |
| Intuity Medical INC | $84.10 | 2022-2023 | Pogo Automatic Blood Glucose Monitoring System |
| Valeritas, INC. | $78.67 | 2019 | |
| Ibsa Pharma INC. | $77.60 | 2020-2024 | Licart, Tirosint |
| Companion Medical, INC. | $77.41 | 2019-2020 | |
| Antares Pharma, INC. | $75.28 | 2020-2024 | Xyosted |
| Ascensia Diabetes Care US INC. | $70.16 | 2021-2024 | |
| Verity Pharmaceuticals INC. | $61.60 | 2024-2025 | Tlando |
| Sequel Med Tech, LLC | $51.75 | 2025 | Twiist |
| Esperion Therapeutics, INC. | $51.70 | 2023-2024 | Nexletol |
| Ultragenyx Pharmaceutical INC. | $50.71 | 2020-2023 | |
| Tolmar, INC. | $48.02 | 2023-2025 | Jatenzo |
| Endo Pharmaceuticals INC. | $46.76 | 2020-2024 | Aveed |
| Horizon Therapeutics Plc | $42.56 | 2022-2023 | Tepezza |
| Novartis Pharmaceuticals Corporation | $41.70 | 2023 | |
| Globus Medical, INC. | $40.42 | 2025 | Omnia, Senza |
| Acella Pharmaceuticals, LLC | $34.08 | 2024-2025 | NP Thyroid 60 |
| Medtronic Minimed, INC. | $31.07 | 2020 | |
| Axsome Therapeutics, INC. | $30.29 | 2023 | Sunosi |
| Halozyme INC | $29.85 | 2023 | |
| Pfizer INC. | $29.63 | 2023 | |
| Rgh Enterprises LLC | $27.58 | 2025 | |
| Amneal Pharmaceuticals LLC | $23.91 | 2022 | |
| Amryt Pharma Holdings LTD | $23.77 | 2023 | Juxtapid |
| Amarin Pharma, INC. | $23.52 | 2020 | |
| Astellas Pharma US INC | $20.36 | 2025 | Veozah |
| Avvisto Therapeutics, LLC | $20.20 | 2025 | Cycloset |
| Acerus Pharmaceuticals Corporation | $19.38 | 2020 | |
| Amphastar Pharmaceuticals, INC. | $18.86 | 2023 | Baqsimi |
| Medicure Pharma INC. | $16.38 | 2021 | |
| Grt US Holding, INC. | $13.69 | 2021 | |
| Ferring Pharmaceuticals INC. | $13.53 | 2019 | |
| Eusa Pharma (US) LLC | $13.38 | 2022 | |
| Nestle Healthcare Nutrition INC. | $13.03 | 2020 | |
| Clarus Therapeutics INC. | $11.63 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $11.36 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Muhammad Choudhry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.